Long Progression-free Survival with First-line Erlotinib in the Treatment of EGFR Mutation Positive Metastatic Lung Adenocarcinoma: Case Report
Journal Title: Scholars Journal of Medical Case Reports - Year 2015, Vol 3, Issue 5
Abstract
Abstract: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib, are known to play a significant role in EGFR mutation positive non-small cell lung cancer. We report long progression-free survival with first-line Erlotinib an EGFR mutation NSCLC. The present study reports the case of an 83-year-old female never smoker was diagnosed with EGFR NSCLC deletions in exon 19 after bone biopsy following pathologic fracture of the right femur. The patient received Erlotinib after palliative femoral radiotherapy. Currently, the patient is stable, with no evidence of disease progression after 36 months of treatment with Erlotinib. We describe the disease and the treatment safety using Erlotinib in the elderly patient. Keywords: Erlotinib, Epidermal growth factor receptor, Tyrosine kinase inhibitors, Non-small cell lung cancer.
Authors and Affiliations
Ahmedou TOULBA
Keywords
Related Articles
- EP ID EP377358
- DOI -
- Views 78
- Downloads 0
An Interesting Case of Paediatric Penetrating Head Trauma by a Wedge of Concrete
Traumatic Brain Injury is among the leading cause of morbidity and mortality in modern times. Data suggests that almost 50 % of all trauma related deaths are secondary to traumatic brain injuries (TBI). Penetrating head...
Adrenal Myelolipoma an Unusual Finding in a Patient of Major Depressive Disorder with Somatic Symptoms – A Case Report
Major depressive disorder & somatic pain are commonly associated and frequently presented in Psychiatry outpatient department. Proper treatment of depression leads to simultaneous relief of somatic pain. Here we report a...
Challenges in Managing Locally Aggressive Pelvic Chondrosarcoma: A Case Report
Chondrosarcoma (CS) is a primary bone malignancy which differentiated from the cartilage tissue. It accounts for approximately 20% of malignant bone tumours. It ranks the third most common primary bone malignancy after o...
Composite Tumour of the Rectum: A Diagnostic Dilemma
Rectal adenocarcinoma with additional neuroendocrine component is an extremely rare entity with about a little more a dozen of cases being reported in the literature. Mostly the neuroendocrine component is that of well-d...
Direct bonded prosthesis using avulsed tooth: A novel technique for esthetic rehabilitation in growing children
Avulsion and luxation account for up to 16% of all traumatic injuries in the permanent dentition and 7.2% of injuries in the primary dentition. A range of treatment options exist to bridge the space created, depending on...